0
0

Respiratory Syncytial Virus (RSV) Impact Act

12/30/2022, 3:34 AM

Congressional Summary of S 3364

Respiratory Syncytial Virus (RSV) Impact Act

This bill requires the Department of Health and Human Services to contract with the National Academy of Sciences for a study on respiratory syncytial virus (RSV) transmission in schools and day cares. In particular, the study must evaluate the impact of RSV on the economy, including through parents' absences from work.

RSV is a common respiratory virus that typically causes mild, cold-like symptoms although it may be more serious for infants, older adults, and other vulnerable populations.

Current Status of Bill S 3364

Bill S 3364 is currently in the status of Bill Introduced since December 9, 2021. Bill S 3364 was introduced during Congress 117 and was introduced to the Senate on December 9, 2021.  Bill S 3364's most recent activity was Read twice and referred to the Committee on Health, Education, Labor, and Pensions. as of December 9, 2021

Bipartisan Support of Bill S 3364

Total Number of Sponsors
1
Democrat Sponsors
0
Republican Sponsors
1
Unaffiliated Sponsors
0
Total Number of Cosponsors
0
Democrat Cosponsors
0
Republican Cosponsors
0
Unaffiliated Cosponsors
0

Policy Area and Potential Impact of Bill S 3364

Primary Policy Focus

Health

Alternate Title(s) of Bill S 3364

Respiratory Syncytial Virus (RSV) Impact Act
Respiratory Syncytial Virus (RSV) Impact Act
A bill to provide for a study on the transmission of respiratory syncytial virus transmission in schools and daycare facilities.

Comments